TheKicksShrink

TheKicksShrink Podcast

TheKicksShrink

  • Minisode 34: Mydayis for ADHD Review - Is This "Super Adderall"?

Minisode 34: Mydayis for ADHD Review - Is This "Super Adderall"?

Wednesday 17th May 2023

Dr. Sulman Aziz Mirza reviews Mydayis, an alternative ADHD medication, discussing its unique features and patient experiences on TheKicksShrink Podcast.
Explicit
7 minutes
Informative
Empowering
Supportive
Hopeful
Transformative

About this podcast

TheKicksShrink Podcast
Author:
TheKicksShrink
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Recovery from Trauma
Mindfulness & Technology in Health
Sexual Stigmas & Myths
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Mydayis for ADHD: Is It Really the 'Super Adderall'?

Episode Overview

  • Mydayis offers up to 16 hours of steady release with its long-acting formulation
  • Positive patient feedback highlights Mydayis as a smoother and more consistent experience compared to Adderall and Vyvanse
  • Consulting with a healthcare professional is crucial to determine the best ADHD medication option
  • Navigating the ongoing Adderall shortage necessitates exploring alternative treatment options
  • Mydayis presents a promising choice for extended work or study hours
Most of them have done great on it and actually prefer it to Adderall and Vyvanse, with the main feedback being that it is a smoother and more even experience for them.
If you're grappling with the Adderall shortage and seeking alternatives, this episode of TheKicksShrink Podcast might be just what you need. Dr. Sulman Aziz Mirza, a triple board-certified psychiatrist, takes a close look at Mydayis, a medication that's gaining attention as a potential game-changer for ADHD treatment. Mydayis stands out with its unique long-acting formulation, offering up to 16 hours of steady release thanks to its innovative Triple Bead Release technology. Dr.
Mirza breaks down how this medication works, its potential side effects, and why it might be a better option for some patients compared to Adderall or Vyvanse. He also shares feedback from his patients who have found Mydayis to provide a smoother and more consistent experience, particularly for those with demanding schedules. This episode is packed with practical information and insights, making it a must-listen for anyone navigating ADHD treatment options during these challenging times.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.